Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

Biological Psychiatry
Andrew H MillerCharles L Raison

Abstract

Recognition that inflammation may represent a common mechanism of disease has been extended to include neuropsychiatric disorders including major depression. Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines, which have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter metabolism, neuroendocrine function, and neural plasticity. Indeed, activation of inflammatory pathways within the brain is believed to contribute to a confluence of decreased neurotrophic support and altered glutamate release/reuptake, as well as oxidative stress, leading to excitotoxicity and loss of glial elements, consistent with neuropathologic findings that characterize depressive disorders. Further instantiating the link between inflammation and depression are data demonstrating that psychosocial stress, a well-known precipitant of mood disorders, is capable of stimulating inflammatory signaling molecules, including nuclear factor kappa B, in part, through activation of sympathetic nervous system outflow pathways. Interestingly, depressed patients with increased in...Continue Reading

References

Oct 1, 1991·Neurochemical Research·C Rios, A Santamaria
Aug 1, 1993·The American Journal of Psychiatry·M MaesE Suy
Feb 1, 1996·Endocrine Reviews·H O Besedovsky, A del Rey
Jan 1, 1996·Advances in Neuroimmunology·J Zielasek, H P Hartung
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·D OngürJ L Price
Mar 4, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S LanquillonH Vedder
Mar 17, 2000·The Journal of Clinical Endocrinology and Metabolism·A N VgontzasG P Chrousos
Mar 10, 2001·Nature·L Chang, M Karin
Mar 29, 2001·The New England Journal of Medicine·D L MusselmanA H Miller
Mar 29, 2001·Biological Psychiatry·C M Pariante, A H Miller
Apr 3, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R YirmiyaJ Weidenfeld
Apr 5, 2001·American Journal of Physiology. Endocrinology and Metabolism·P A KernG Ranganathan
May 16, 2001·Archives of General Psychiatry·A ReichenbergT Pollmächer
Sep 22, 2001·Brain, Behavior, and Immunity·E P ZorrillaK Schmidt
Apr 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lucile CapuronAndrew H Miller
Jul 26, 2002·Psychosomatic Medicine·Julienne E BowerJohn L Fahey
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Robert Schwarcz, Roberto Pellicciari
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Francesco BenedettiEnrico Smeraldi
Dec 6, 2002·The International Journal of Neuropsychopharmacology·Gunter Kenis, Michael Maes
Feb 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Angelika BierhausPeter P Nawroth
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Younger W-Y YuShih-Jen Tsai
Jun 10, 2003·Annals of the New York Academy of Sciences·Michael S HarbuzDavid S Jessop
Mar 12, 2004·Biological Psychiatry·Massihullah HamidiJoseph L Price
Jul 10, 2004·Trends in Cognitive Sciences·Naomi I Eisenberger, Matthew D Lieberman
Sep 11, 2004·Psychoneuroendocrinology·Julienne E BowerJohn L Fahey
Sep 24, 2004·Journal of Neurochemistry·Laura M Borland, Adrian C Michael
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tyvin RichFrancis Lévi
Mar 24, 2005·Psychosomatic Medicine·Sarosh J MotivalaMichael R Irwin
May 19, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Agnès NadjarPatricia Parnet
Jun 1, 2005·Brain, Behavior, and Immunity·Valentin A Pavlov, Kevin J Tracey
Jul 19, 2005·Nature Reviews. Neuroscience·Andrea Volterra, Jacopo Meldolesi
Aug 9, 2005·Biological Psychiatry·Lucile CapuronAndrew H Miller

❮ Previous
Next ❯

Citations

Mar 24, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·K-H Schulz, F Thaiss
Oct 26, 2012·Der Nervenarzt·D PiberC Otte
Sep 29, 2011·Psychopharmacology·Kamilla W MiskowiakLars V Kessing
Oct 1, 2013·European Archives of Psychiatry and Clinical Neuroscience·Julian Hellmann-RegenChristian Otte
Aug 6, 2010·Journal of Neural Transmission·Bárbara TagliariAngela T S Wyse
Jun 2, 2012·Journal of Neural Transmission·Harris Eyre, Bernhard T Baune
Jan 29, 2013·Journal of Neural Transmission·Kurt A Jellinger
Mar 1, 2012·Inflammopharmacology·Parto S Khansari, Beata Sperlagh
Nov 15, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rita Businaro
May 7, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sinead M Gibney, Hemmo A Drexhage
Nov 6, 2009·Current Pain and Headache Reports·Michael T SmithAdeel Nasir
Jun 15, 2011·Current Psychiatry Reports·Madeline LiSidney H Kennedy
Sep 20, 2011·Current Psychiatry Reports·Charles L Raison, Andrew H Miller
Nov 19, 2011·Current Psychiatry Reports·Renee D Goodwin
Apr 6, 2011·Journal of Molecular Neuroscience : MN·Paulina BorkowskaJan Kowalski
Nov 7, 2013·Advances in Therapy·Celina S LiuRoger S McIntyre
Feb 25, 2010·International Journal of Behavioral Medicine·Michael ChaitonMarie Lambert
Mar 20, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Eduardo A PinedaAndréy M Mazarati
Nov 13, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Timothy R PowellUrsula M D'Souza
Jun 15, 2013·Neuropharmacology·Mark R Hutchinson, Linda R Watkins
Apr 18, 2013·Asian Pacific Journal of Tropical Biomedicine·Urmila M AswarSubhash L Bodhankar
Aug 3, 2012·Nutrition Research Reviews·E R Ellsworth-Bowers, E J Corwin
May 9, 2012·Development and Psychopathology·Daniel R Hanson, Irving I Gottesman
Dec 18, 2013·Development and Psychopathology·Terrie E Moffitt, UNKNOWN Klaus-Grawe 2012 Think Tank
Aug 10, 2012·International Psychogeriatrics·Matt Bennett ParadiseIan Bernard Hickie
Mar 23, 2012·Palliative & Supportive Care·James K RustadM Beatriz Currier
Apr 20, 2011·Behavioral Neuroscience·Michael B HennessyTerrence Deak
Feb 17, 2010·Molecular Psychiatry·A DaneseL Arseneault

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2021 Meta ULC. All rights reserved